Viemed Healthcare, Inc. (VMD)

In the past six months, Viemed Healthcare, Inc. announced record full-year 2025 financial results and a new 2026 share repurchase program, completed the acquisition of Lehan's Medical Equipment, reported strong revenue and cash flow for Q3 2025, reported Q4 2025 earnings per share (EPS) of $0.14, President Michael Moore reported selling 136,802 common shares indirectly held through Moore Faster LLC, and an updated National Coverage Determination (NCD) introduced new documentation and tightened coverage criteria.

Viemed Healthcare, Inc. experiences some demand seasonality, with the first quarter (Q1) traditionally being its weakest. The company has reported strong growth trends in ventilator and PAP therapy patient counts in Q1, which bodes well for subsequent quarters. The company's growth is also influenced by the increasing shift towards in-home care and accelerating adoption of sleep and resupply services.

Viemed Healthcare, Inc. (VMD) is a national provider of in-home, technology-enabled post-acute respiratory care services and home medical equipment (HME) in the United States. The company focuses on treating patients with chronic respiratory conditions in their homes, combining respiratory equipment with clinician-led care, education, and counseling. Major products and services include non-invasive and invasive ventilation (NIV) devices, BiPAP and CPAP devices, oxygen concentrators and oxygen therapy, airway clearance and secretion management equipment, in-home sleep apnea testing services, respiratory disease management, healthcare staffing and recruitment services, and maternal health products.

Viemed Healthcare, Inc. serves a broad geographic footprint across all 50 states of the United States and is headquartered in Lafayette, Louisiana.

Viemed Healthcare, Inc. is described as a national leader in technology-enabled post-acute respiratory care, built on providing in-home clinical care with a focus on improving patient outcomes and reducing healthcare costs. Announcing record financial performance, strategic acquisitions, share repurchase programs, and adaptation to regulatory changes have affected its reputation positively.

Viemed Healthcare, Inc. has a significant portion of its shares held by institutional investors, approximately 61.73% to 65.58% of the company's shares. Major institutional owners include BlackRock, Inc., Forager Capital Management, LLC, and Vanguard Group Inc. Individual insiders own approximately 13.6% to 13.83% of the company, with Casey Hoyt, CEO & Director, being the largest individual shareholder.